Venous Thromboembolism in Primary Pancreatic Tumour Resection

Launched by UNIVERSITY OF THESSALY · Jul 27, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a condition called venous thromboembolism (VTE) in patients with pancreatic cancer who are having surgery to remove their tumors. VTE is a serious condition where blood clots form in the veins, and the researchers want to understand how often this happens and what factors might contribute to it in people undergoing pancreatic surgery. The trial is currently looking for participants at the University Hospital of Larissa.

To be eligible for this study, patients must be diagnosed with pancreatic cancer and be scheduled for surgery to remove the tumor. Those who have had a blood clot in the last six months, have certain bleeding disorders, or have other serious health issues may not be able to participate. If you join the study, you can expect to undergo regular assessments to monitor your health and the development of any blood clots during your treatment. Your involvement could help improve care for future patients with pancreatic cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Consecutive pancreatic cancer patients undergoing pancreatic cancer resection in University Hospital of Larissa, after informed consent will be included.
• Exclusion Criteria:
• • Refuse to participate
• • Previous thromboembolic event \< 6 months prior to the operation
• • History of inherited or acquired bleeding disorder
• • ASA PS \> 3
• • Concomitant presence of a second primary malignancy
• • Unresectable pancreatic cancer